Trial intelligence / Profile preview

Duloxetine in Chronic Fatigue Syndrome

NCT00375973Phase 3Completed

Sponsor
University of Cincinnati
Start
Sep 2006
Primary completion
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of duloxetine in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), sponsored by University of Cincinnati. Started Sep 2006; status: completed.

02

Drugs

duloxetine
03

Conditions

myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)

Beyond the preview

Go deeper on NCT00375973.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00375973.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call